Shingrix is a brand-new recombinant, non-live adjuvanted shingles vaccine. More than 90% protection against shingles and postherpetic neuralgia (PHN), the most frequent consequence of shingles, is offered by two doses of Shingrix.

Who needs Shingrix?

Give Shingrix to immunocompetent individuals aged 50 and older who have experienced shingles in the past, received Zostavax® at least 8 weeks prior, have a medical condition like chronic renal failure, diabetes mellitus, rheumatoid arthritis, or chronic pulmonary disease, are receiving other vaccinations like the influenza and pneumococcal vaccines at the same visit, and are receiving low-dose immunosuppressive therapy.

Who shouldn't purchase Shingrix?

Patients who have ever experienced a severe allergic reaction, such as anaphylaxis, to a component of this vaccine or who have taken Shingrix within the past two weeks should not get Shingrix. If your patient is expecting, nursing, or going through an acute shingles attack, you might want to postpone the immunisation.

Insurance and price

The majority of health insurance plans now cover Shingrix. Inform your patients to check with their health insurance companies in advance to determine if the vaccine is covered.

Patient counselling regarding Shingrix

Learn about the advantages and disadvantages of Shingrix so you can discuss them with your patients before giving them the shot. After taking Shingrix, most patients have soreness in their arms. Many people suffer several-inch-long redness and swelling where they had the injection on their arm. Many folks also felt fatigued or had headaches, shivers, fevers, stomachaches, or nausea. One in six people had symptoms that were severe enough to keep them from engaging in daily activities. For a few days following immunisation, you should prepare to refrain from heavy activity. Usually, side effects disappear within two to three days. If you have any adverse effects, you may decide to use an over-the-counter pain reliever such acetaminophen or ibuprofen. You can use the website to report any negative side effects to the Vaccine Adverse Event Reporting system.

Reference:- https://www.cdc.gov/shingles/multimedia/shingles-factsheet-hcp.html#:~:text=Adults%2050%20years%20and%20older%20should%20receive%202%20doses%20of,of%2036%2D46%C2%B0%20F